期刊文献+

肝纤维化动物模型研究进展与评价 被引量:1

Progress and evaluation of animal models of liver fibrosis
原文传递
导出
摘要 肝硬化全球发病率高,危害大。肝纤维化是肝硬化的早期表现,病程可逆。肝纤维化动物模型是研究肝硬化的重要手段之一。常用的肝纤维化动物模型包括化学毒物诱导模型、外科手术干预诱导模型、饮食诱导模型及乙肝病毒模型等,均存在一定的局限性,不能较好地模拟临床实际肝纤维化发病进程。本文对目前肝纤维化动物模型研究进展进行综述和展望。 Liver cirrhosis has a high global incidence rate and great harm.Liver fibrosis is the early stage of liver cirrhosis,which is reversible.The animal model of liver fibrosis is one of the important means to study liver cirrhosis.The commonly used animal models of liver fibrosis include chemical toxicant induction model,surgical intervention induction model,diet induction model and hepatitis B virus model.However,all of them have certain limitations and cannot well simulate the actual clinical course of liver fibrosis.This article reviews and prospects the research progress of animal models of liver fibrosis.
作者 向涛 袁观斗 吕军 何松青 Xiang Tao;Yuan Guandou;Lyu Jun;He Songqing(Division of Hepatobiliary Surgery,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China;Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases(Guangxi Medical University),Nanning 530021,China)
出处 《中华实验外科杂志》 CAS 北大核心 2023年第3期591-594,共4页 Chinese Journal of Experimental Surgery
基金 国家重点研发计划(2022YFE0131600) 国家自然科学基金(82160500) 111计划(D17011) 中央引导地方科技发展专项(ZY20198011) 广西科技基地和人才专项(桂科AA21220002) 广西自然科学基金(2022GXNSFAA035642)。
关键词 肝纤维化 肝硬化 慢性肝病 动物模型 Liver cirrhosis Liver fibrosis Chronic liver disease Animal model
  • 相关文献

参考文献1

二级参考文献17

  • 1Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6:411-425.
  • 2Zhou XN, Wang LY, Chen MG, Wu XH, Jiang QW, Chen XY, Zheng J, Utzinger J. The public health significance and control of schistosomiasis in China=then and now. Acta Trap 2005; 96: 97-105.
  • 3Gryseels B, Polman K, Clerinx J, Kestens 1. Human schistosomiasis. Lancet 2006; 368: 1106-1118.
  • 4Boros D1. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 1989; 2: 250-269.
  • 5Wilson MS, Mentink-Kane MM, Pesce jr. Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Bioi 2007; 85: 148-154.
  • 6Chapadeiro E, Pitanga LC. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study]. Rev Soc Bras Med Trap 1996; 30: 53-56.
  • 7Nanas IN, Kontoyannis DA, Alexopoulos GP, AnastasiouNana MI, Tsagalou EP, Stamatelopoulos SF, Moulopoulos SD. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure. Chest 2001; 119: 1173-1178.
  • 8Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 2005; 207: 25-38.
  • 9Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004; 287: G264-G273.
  • 10Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am J Patho11962; 41: 711-731.

共引文献5

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部